Akshay Vaishnaw
Director/Board Member at SCHOLAR ROCK HOLDING CORPORATION
Net worth: 3 M $ as of 30/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Edward Myles | M | 52 |
Scholar Rock, Inc.
 Scholar Rock, Inc. BiotechnologyHealth Technology Scholar Rock, Inc. operates as a biotechnology company. It focuses on discovering and developing a novel class of biologic therapies that target supracellular activation of growth factors in the disease microenvironment. The company was founded by Timothy Springer and Leonard Zon and is headquartered in Cambridge, MA. | 6 years |
| Erin Moore | F | 49 |
Scholar Rock, Inc.
Scholar Rock, Inc. BiotechnologyHealth Technology Scholar Rock, Inc. operates as a biotechnology company. It focuses on discovering and developing a novel class of biologic therapies that target supracellular activation of growth factors in the disease microenvironment. The company was founded by Timothy Springer and Leonard Zon and is headquartered in Cambridge, MA. | 6 years |
| Gilmore O’Neill | M | 59 | 18 years | |
| Amir Nashat | M | 51 |
Scholar Rock, Inc.
Scholar Rock, Inc. BiotechnologyHealth Technology Scholar Rock, Inc. operates as a biotechnology company. It focuses on discovering and developing a novel class of biologic therapies that target supracellular activation of growth factors in the disease microenvironment. The company was founded by Timothy Springer and Leonard Zon and is headquartered in Cambridge, MA. | 12 years |
| Michael Gilman | M | 69 |
Scholar Rock, Inc.
Scholar Rock, Inc. BiotechnologyHealth Technology Scholar Rock, Inc. operates as a biotechnology company. It focuses on discovering and developing a novel class of biologic therapies that target supracellular activation of growth factors in the disease microenvironment. The company was founded by Timothy Springer and Leonard Zon and is headquartered in Cambridge, MA. | 18 years |
| David Hallal | M | 57 |
Scholar Rock, Inc.
Scholar Rock, Inc. BiotechnologyHealth Technology Scholar Rock, Inc. operates as a biotechnology company. It focuses on discovering and developing a novel class of biologic therapies that target supracellular activation of growth factors in the disease microenvironment. The company was founded by Timothy Springer and Leonard Zon and is headquartered in Cambridge, MA. | 10 years |
| Michael Bonney | M | 65 | 17 years | |
| Yvonne Greenstreet | M | 61 | 8 years | |
| Richard Brudnick | M | 67 | 17 years | |
| Chris Kiefer | M | - | 7 years | |
| Jay Backstrom | M | 69 | 2 years | |
| Bernadette Connaughton | F | 65 | 7 years | |
| Andrew Hirsch | M | 53 | 17 years | |
| Emma Reeve | F | 63 | 3 years | |
| Jeffrey Flier | M | 76 |
Scholar Rock, Inc.
Scholar Rock, Inc. BiotechnologyHealth Technology Scholar Rock, Inc. operates as a biotechnology company. It focuses on discovering and developing a novel class of biologic therapies that target supracellular activation of growth factors in the disease microenvironment. The company was founded by Timothy Springer and Leonard Zon and is headquartered in Cambridge, MA. | 8 years |
| Kristina Burow | F | 50 |
Scholar Rock, Inc.
Scholar Rock, Inc. BiotechnologyHealth Technology Scholar Rock, Inc. operates as a biotechnology company. It focuses on discovering and developing a novel class of biologic therapies that target supracellular activation of growth factors in the disease microenvironment. The company was founded by Timothy Springer and Leonard Zon and is headquartered in Cambridge, MA. | 10 years |
| Peter Kellogg | M | 67 | 6 years | |
| Phillip Sharp | M | 79 | 22 years | |
| Amy Schulman | F | 63 | 10 years | |
| Jing Marantz | M | 59 | 5 years | |
| Jessica Hopfield | M | 59 | 6 years | |
| Joshua Reed | M | 51 | 3 years | |
| Carolyn Bertozzi | M | 57 | 1 years | |
| Christine Regan Lindenboom | F | 43 | 9 years | |
| Srini Akkaraju Akkaraju | M | 56 | 2 years | |
| Elliott Levy | M | 64 | 1 years | |
| Jun Lin Ho | F | 45 | 6 years | |
| Jeffrey Poulton | M | 56 | 5 years | |
| Charlene Stern | M | - | 11 years | |
| Rushmie Nofsinger | F | - | 3 years | |
| Joshua Brodsky | M | - | 3 years | |
| Kevin Fitzgerald | M | 56 | 19 years | |
| David Pyott | M | 70 | 9 years | |
| Sara Nochur | M | 63 | 18 years | |
| Meeta Chatterjee | M | 69 | 4 years | |
| Charles Sigal | M | 72 | 2 years | |
| Margaret Hamburg | M | 68 | 5 years | |
| Katie Peng | F | - | - | |
| Susan Alexander | F | 67 | 21 years | |
| Colleen Reitan | F | 64 | 6 years | |
| Dennis Ausiello | M | 78 | 12 years | |
| David Scadden | M | 71 | 5 years | |
| Olivier Brandicourt | M | 68 | 4 years | |
| Todd Curtis | M | - | 9 years | |
| Timothy J. Maines | M | - | 7 years | |
| Richard Philipson | M | 60 |
The Royal College of Physicians
| - |
| Rosh Dias | M | - |
The Royal College of Physicians
| - |
| Alexandra Sinclair | M | - |
The Royal College of Physicians
| - |
| Steve Knowles | M | - |
The Royal College of Physicians
| - |
| Man Yung Cheng | M | 74 |
The Royal College of Physicians
| 44 years |
| Ka Shing Yan | M | 38 |
The Royal College of Physicians
| - |
| Karen Atkin | M | 58 |
The Royal College of Physicians
| - |
| Essra Ridha | M | 41 |
The Royal College of Physicians
| - |
| Monica Shaw | M | 46 |
The Royal College of Physicians
| - |
| Zaki Morad bin Mohamad Zaher | M | 74 |
The Royal College of Physicians
| - |
| Cristi Barnett | M | - | - | |
| Rupert Vessey | M | 59 |
The Royal College of Physicians
| - |
| Emmet B. Keeffe | M | - |
The Royal College of Physicians
| - |
| Adam Craig | M | 58 |
The Royal College of Physicians
| - |
| Helen Torley | M | 61 |
The Royal College of Physicians
| - |
| Yiu Nam Lau | M | 63 |
The Royal College of Physicians
| 37 years |
| Roger A. Perrault | M | 87 |
The Royal College of Physicians
| 44 years |
| Patricia Smith | M | - |
The Royal College of Physicians
| 40 years |
| Peter Richardson | M | 64 |
The Royal College of Physicians
| - |
| Stephen L. Bandak | M | 74 |
The Royal College of Physicians
| 47 years |
| Kemal Malik | M | 61 |
The Royal College of Physicians
| - |
| Stephen Lockhart | M | 67 |
The Royal College of Physicians
| 41 years |
| Chrisantha Nicholas Nonis | M | - |
The Royal College of Physicians
| - |
| Mike Anderson | M | - |
The Royal College of Physicians
| - |
| Lewis J. Rubin | M | - |
The Royal College of Physicians
| - |
| Kim Chan Koh | M | - |
The Royal College of Physicians
| - |
| Peter Gardiner | M | - |
The Royal College of Physicians
| - |
| Chee Siong Soo | M | 63 |
The Royal College of Physicians
| - |
| Charles Q. Morris | M | 59 |
The Royal College of Physicians
| - |
| Brian John O’Keeffe | M | - |
The Royal College of Physicians
| - |
| Andrew Richard Rut | M | 63 |
The Royal College of Physicians
| - |
| Kei Siong Khoo | M | 62 |
The Royal College of Physicians
| - |
| Suyash Prasad | M | 54 |
The Royal College of Physicians
| - |
| Lindsey Rolfe | M | 56 |
The Royal College of Physicians
| - |
| Ash Soman | M | - |
The Royal College of Physicians
| - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Nagesh Mahanthappa | M | 59 |
Scholar Rock, Inc.
Scholar Rock, Inc. BiotechnologyHealth Technology Scholar Rock, Inc. operates as a biotechnology company. It focuses on discovering and developing a novel class of biologic therapies that target supracellular activation of growth factors in the disease microenvironment. The company was founded by Timothy Springer and Leonard Zon and is headquartered in Cambridge, MA. | 16 years |
| Tony Kingsley | M | 60 |
Scholar Rock, Inc.
Scholar Rock, Inc. BiotechnologyHealth Technology Scholar Rock, Inc. operates as a biotechnology company. It focuses on discovering and developing a novel class of biologic therapies that target supracellular activation of growth factors in the disease microenvironment. The company was founded by Timothy Springer and Leonard Zon and is headquartered in Cambridge, MA. | 1 years |
| Timothy Springer | M | 76 |
Scholar Rock, Inc.
Scholar Rock, Inc. BiotechnologyHealth Technology Scholar Rock, Inc. operates as a biotechnology company. It focuses on discovering and developing a novel class of biologic therapies that target supracellular activation of growth factors in the disease microenvironment. The company was founded by Timothy Springer and Leonard Zon and is headquartered in Cambridge, MA. | 7 years |
| Kevin Bitterman | M | 47 | 11 years | |
| John Clarke | M | 70 | 17 years | |
| David Arkowitz | M | 62 | 5 years | |
| Dinah Sah | M | 63 | 13 years | |
| Mike Mason | M | 49 | 14 years | |
| Katrine Bosley | F | 56 | 5 years | |
| John Maraganore | M | 60 | 19 years | |
| Paul Schimmel | M | 83 | 18 years | |
| James Mullen | M | 65 | 5 years | |
| William Young | M | 79 | 11 years | |
| James Tobin | M | 79 | 5 years | |
| Cynthia Collins | F | 65 | 3 years | |
| Rhonda M. Chicko | F | 58 | 4 years | |
| Sylvie Grégoire | M | 63 | 8 years | |
| Robert A. Hamm | M | 72 | 7 years | |
| Paul Clancy | M | 62 | 16 years | |
| Craig Eric Schneier | M | 76 | 8 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 66 | 66.00% |
| United Kingdom | 34 | 34.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Akshay Vaishnaw
- Personal Network
